Skip to main content
Equibles

Elizabeth L. Williams

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

About Elizabeth L. Williams

Immucell Corp /De/ reported in an 8-K filed December 9, 2024 that Elizabeth L. Williams retired as Vice President of Manufacturing Operations, effective July 1, 2025. The proxy statement of Immucell Corp /De/ reports total compensation of $318,913 for Elizabeth L. Williams in fiscal 2024, including a base salary of $295,624. Disclosed compensation is on record for 7 fiscal years.

“As we discussed, your employment at ImmuCell Corporation \(the “Company”\) will change from full time to part time effective December 7, 2024, and you have elected to voluntarily retire effective July 1, 2025 \(the “Separation Date”\).”
Immucell Corp /De/ Form 8-K, filed December 9, 2024 · Read the filing

Summary generated from SEC filings and earnings-call records held by Equibles.

Affiliation history

Recorded current and former roles; source labels appear when available.

Company network

Recorded roles and call appearances connecting this person to public companies.

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year Company Salary Total
2024 Immucell Corp /De/ (ICCC) $295,624 $318,913
2023 Immucell Corp /De/ (ICCC) $264,173 $312,072
2022 Immucell Corp /De/ (ICCC) $254,678 $279,938
2021 Immucell Corp /De/ (ICCC) $245,612 $265,120
2020 Immucell Corp /De/ (ICCC) $236,165 $255,648
2019 Immucell Corp /De/ (ICCC) $227,327 $278,494
2018 Immucell Corp /De/ (ICCC) $220,706 $273,530

Recent activity

Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.